Skip to main content

A PHASE 3 EFFICACY AND SAFETY STUDY OF FOSMANOGEPIX FOR THE TREATMENT OF ADULT PARTICIPANTS WITH INVASIVE MOLD INFECTIONS

Research Grant
Duke Scholars

Awarded By

Basilea Pharmaceutica

Start Date

September 1, 2026

End Date

May 31, 2029
 

Awarded By

Basilea Pharmaceutica

Start Date

September 1, 2026

End Date

May 31, 2029